Creative Biolabs

Ethosome based Targeted Drug Delivery Solution

The challenge of targeted delivery, especially across the formidable skin barrier, often impedes the translation of promising therapeutics. Our Ethosomes-based Delivery Systems Solution at Creative Biolabs helps you accelerate drug development and enhance therapeutic efficacy by leveraging highly flexible, ethanol-enriched nanovesicles designed for superior transdermal and dermal permeation. This advanced solution ensures optimal drug stability and delivery to deep skin layers or systemic circulation.

Click Here to View more about our Services

Introduction of Ethosomes-based Delivery Systems

Ethosomes represent a specialized, soft, and elastic type of lipid-based vesicular carrier, notably distinct from conventional liposomes due to their high concentration of ethanol (typically 20% to 45%). This unique blend of phospholipids (such as phosphatidylcholine), high-concentration ethanol, and water creates a highly deformable nanovesicle capable of significantly enhancing skin penetration.

Fig.1 Schematic of the structure of different ethosomes. (OA Literature)Fig.1 The structure of different ethosomes.1,4

The mechanism of action for ethosomes is synergistic, involving two key effects:

Ethanol Effect

The high ethanol content penetrates the stratum corneum, interacting with the intercellular lipids. This fluidizes the lipid structure, increasing its permeability and acting as a pathway opener.

Ethosome Effect

The high concentration of ethanol makes the ethosomal membrane less tightly packed and highly flexible. This malleability allows the ethosomes to squeeze through the now-fluidized, narrow intercellular spaces of the skin, delivering the encapsulated drug deep into the epidermis and dermis, or even into the systemic circulation.

This system is particularly critical for drugs that are poorly absorbed orally, susceptible to first-pass metabolism, or require localized high concentration without systemic side effects. The non-toxic nature of their components, which are generally recognized as safe (GRAS), further supports their use in both pharmaceutical and cosmeceutical products.

Applications of Ethosomes-based Delivery Systems

The enhanced skin permeation capabilities of Ethosomes have unlocked extensive therapeutic and cosmeceutical applications, providing a non-invasive administration route with improved bioavailability and patient compliance.

Pharmaceutical Applications

Transdermal Drug Delivery

Ethosomes are highly effective for systemic delivery of therapeutic agents that are otherwise challenging to administer, such as hormones (e.g., testosterone, estradiol), and anti-hypertensive or analgesic drugs, by ensuring steady plasma levels and avoiding hepatic degradation.

Dermatological Treatments

They significantly boost the local concentration of active ingredients in deep skin layers, making them ideal for treating chronic conditions like psoriasis, eczema, and severe acne. This enhanced targeting reduces the required dose and minimizes potential systemic side effects.

Anti-Infective Therapy

Ethosomes have been successfully applied in delivering antimicrobial and antifungal agents to treat deep-seated skin infections, where conventional topical formulations often fail to penetrate the fungal or bacterial reservoir effectively.

Vaccination and Immunotherapy

Research indicates the potential of ethosomes as carriers for transcutaneous immunization, efficiently delivering antigens to the immune cells (dendritic cells) within the skin to generate robust systemic and mucosal immune responses.

Cosmeceutical and Aesthetic Applications

Ethosomes enhance the efficacy of active ingredients in skincare, such as antioxidants (Vitamin C, E), anti-aging compounds (retinoids, peptides), and skin-whitening agents (kojic acid), by delivering them far beyond the skin surface, maximizing their biological impact.

Practical Research and Experimental Case Studies

Fig.2 Photomicrograph of the optimal metformin-loaded ethosome formula as seen by the TEM. (Mousa, Ibrahim A et al., 2022)

Formulation and Characterization of Metformin-Loaded Ethosomes for Topical Application to Experimentally Induced Skin Cancer in Mice

Topical Cancer Therapy: This study developed metformin-loaded ethosomes for potential treatment of skin cancer. Optimal formulation with 40% ethanol showed enhanced skin penetration and high entrapment efficiency, which is critical for delivering the drug to the deepest layers of the skin where tumor cells reside. This highlights ethosomes' role in non-invasive antitumor delivery.2,4

Fig.3 TEM micrograph of the optimized TAEG formulation (TA-5). Scale bar is indicated. (Akhtar, Naheed et al., 2022)

Fabrication of Ethosomes Containing Tocopherol Acetate to Enhance Transdermal Permeation: In vitro and Ex Vivo Characterizations

Cosmeceutical & Stability: Ethosomal gel was developed to enhance the delivery and stability of Tocopherol Acetate (Vitamin E derivative), a photoprotective agent. The optimized ethosomal gel showed a high drug retention in the skin (51.20%) after 24 hours, significantly higher than a control gel. Furthermore, the formulation maintained excellent stability over a three-month period.3,4

What We Can Offer: Comprehensive Ethosome Development Services

Creative Biolabs provides a fully integrated service suite for developing customized Ethosomes-based Delivery Systems, supporting your project from initial concept to optimized clinical-grade formulation.

Customized Formulation Design

Tailoring lipid and ethanol compositions (Classical, Binary, and Transethosomes) to optimize encapsulation efficiency and deformability for your specific therapeutic cargo (hydrophilic, lipophilic, or macromolecules).

Payload Encapsulation and Stability Testing

Efficient encapsulation of diverse payloads, including small molecules, peptides, proteins, and nucleic acids, followed by rigorous testing for physical and chemical stability under various storage conditions.

Process Optimization and Scale-Up

Utilization of reproducible and scalable methods (Cold Method, Hot Method, High-Pressure Homogenization) to ensure consistency from lab-scale synthesis to commercial manufacturing.

Physicochemical Characterization

Comprehensive analysis of ethosome formulations, including particle size (from nanometers to microns), zeta potential, morphology (via TEM/SEM), and lamellarity.

In vitro and Ex Vivo Permeation Studies

Detailed assessment of transdermal drug flux and skin deposition using standardized in vitro models and animal/human cadaver skin to predict in vivo performance.

Customization with Targeting Ligands

Modification of the ethosomal surface with specific targeting modules to enhance specificity for certain skin cells or receptors, if required.

FAQs

How does this delivery system fundamentally improve drug absorption compared to basic creams or gels?

This system utilizes specialized, ultra-flexible vesicles containing high levels of a skin penetration enhancer. The enhancer temporarily disrupts the dense lipid barrier of the outermost skin layer, while the deformable vesicles squeeze through these opened pathways, delivering the active compound into the deep layers of the skin or even into the bloodstream. This dual action provides significantly greater depth and quantity of delivery than simple topical application.

Can these nanovesicles deliver large molecules like peptides or proteins effectively across the skin?

Yes, that is a core benefit of this technology. While the skin naturally blocks large macromolecules, the enhanced flexibility and barrier-disrupting component of these vesicles allow them to transport molecules with diverse physicochemical properties, including high molecular weight compounds like certain therapeutic peptides, making non-invasive systemic delivery possible.

What are the key factors that influence the stability and performance of the final formulation?

Stability and performance are highly dependent on the precise ratio of the lipid components to the penetration enhancer, as well as the manufacturing method. Critical factors include maintaining the optimal particle size range (usually between 50 nm to 300 nm) and ensuring the concentration of the enhancer remains at the level required to impart adequate membrane fluidity without compromising the vesicle structure.

Is this system only suitable for deep transdermal delivery, or can it be used for strictly localized, superficial targeting?

While exceptionally good for deep or systemic delivery, the formulation parameters can be adjusted for localized targeting. By modifying the concentrations of the components, the interaction with the skin can be controlled to maximize drug retention within the superficial epidermis, which is beneficial for strictly dermal treatments.

Are there any compatibility concerns when formulating new or sensitive drug compounds into these vesicles?

The formulation process requires careful consideration of the drug's solubility and stability in the presence of the high concentration of the penetration enhancer. Comprehensive pre-formulation studies are essential to select compatible lipids and processing conditions (like temperature and mixing rate) that prevent drug degradation or premature vesicle collapse, thereby ensuring the therapeutic integrity of the final product.

Creative Biolabs' Ethosomes-based Delivery Systems Solution provides an advanced, non-invasive path for delivering challenging therapeutic and cosmetic agents. Our services encompass end-to-end support, from custom formulation and optimization to full physicochemical characterization and ex vivo validation, ensuring you achieve superior transdermal bioavailability and patient compliance for your products.

Reference

  1. Zhan, Bo, et al. "Ethosomes: A promising drug delivery platform for transdermal application." Chemistry 6.5 (2024): 993-1019. https://doi.org/10.3390/chemistry6050058.
  2. Mousa, Ibrahim A et al. "Formulation and Characterization of Metformin-Loaded Ethosomes for Topical Application to Experimentally Induced Skin Cancer in Mice." Pharmaceuticals (Basel, Switzerland) vol. 15,6 657. 25 May. 2022, https://doi.org/10.3390/ph15060657.
  3. Akhtar, Naheed et al. "Fabrication of Ethosomes Containing Tocopherol Acetate to Enhance Transdermal Permeation: In vitro and Ex Vivo Characterizations." Gels (Basel, Switzerland) vol. 8,6 335. 30 May. 2022, https://doi.org/10.3390/gels8060335.
  4. Distributed under Open Access license CC BY 4.0, without modification.
Our services are For Research Use Only. We do not provide services to individuals.
Online Inquiry

Customer Review

Creatibe Biolabs' custom LNP was the only solution that successfully delivered our CRISPR-Cas9 payload across the blood-brain barrier with high efficiency and low toxicity.”

Dr. Evelyn Reed

Postdoctoral Researcher, Leading University

Our siRNA candidate was failing due to off-target toxicity, but Creatibe Biolabs' team rapidly redesigned our LNP using their modular platform, rescuing our preclinical program.”

Ben Carter

Project Manager

Achieving cytosolic delivery of our protein degrader with Creatibe Biolabs' exosome platform was the key to unlocking our candidate's full therapeutic potential.”

Dr. Kenji Tanaka

Principal Scientist, Large Pharma Corp

Our oncology drug's efficacy was limited by poor tumor accumulation. Creatibe Biolabs' peptide-conjugated liposomes provided the precise targeting we needed, dramatically increasing the drug's therapeutic index.”

Dr. Clara Schmidt

Senior Scientist, Oncology Innovations Inc.

We required a delivery system that would only release its payload in the tumor's acidic microenvironment. Creatibe Biolabs' pH-responsive liposomes performed flawlessly, minimizing systemic exposure.”

David Chen

Formulation Scientist

Outstanding expertise in antibody engineering.The team's attention to detail and innovative approaches have sianificantly accelerated our development timeline.

Sarah L.

Senior Research Scientist

Contact us for more information Get free consultations
ad